STEPUPIORS joined forces with ELMUMY and MULTIR EU Project in Athens on October 3, 2024, to enravel collaborative approaches for efficient and effective utilization of funds provided by the European Research Executive Agency.
𝐌𝐔𝐋𝐓𝐈𝐑 is focused on predicting and manipulating immune responses in multiple cancer types, including melanoma, lung, and bladder cancers.
𝐄𝐋𝐌𝐔𝐌𝐘 continues to focus on identifying risk factors and health determinants that lead to the progression of monoclonal gammopathies into multiple myeloma.
𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬 from all three projects showcased innovative research and solutions, and the dynamic 𝐐&𝐀 𝐬𝐞𝐬𝐬𝐢𝐨𝐧𝐬 enabled exploring the impact of potential synergistic approach.